Qiagen (NASDAQ:QGEN – Get Rating) and Monte Rosa Therapeutics (NASDAQ:GLUE – Get Rating) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, dividends, risk, earnings, analyst recommendations, valuation and institutional ownership. Valuation and Earnings This table compares Qiagen and Monte Rosa […]
Shares of Qiagen (NASDAQ:QGEN – Get Rating) gapped up prior to trading on Tuesday . The stock had previously closed at $44.94, but opened at $46.32. Qiagen shares last traded at $46.08, with a volume of 147,440 shares. Analyst Upgrades and Downgrades Separately, StockNews.com initiated coverage on Qiagen in a report on Thursday, May 18th. […]
StockNews.com started coverage on shares of Qiagen (NASDAQ:QGEN – Get Rating) in a research report report published on Thursday morning. The firm issued a buy rating on the stock. Qiagen Trading Up 0.5 % Shares of QGEN opened at $45.15 on Thursday. Qiagen has a one year low of $40.38 and a one year high […]
StockNews.com assumed coverage on shares of Qiagen (NASDAQ:QGEN – Get Rating) in a report issued on Thursday. The brokerage issued a buy rating on the stock. Qiagen Price Performance Qiagen stock opened at $45.15 on Thursday. The company has a market cap of $10.28 billion, a P/E ratio of 29.32, a P/E/G ratio of 8.24 […]
Equities researchers at StockNews.com initiated coverage on shares of Qiagen (NASDAQ:QGEN – Get Rating) in a research report issued to clients and investors on Thursday. The brokerage set a “buy” rating on the stock. Qiagen Price Performance About Qiagen (Get Rating) QIAGEN NV is a holding company, which engages in the provision of Sample to […]